Literature DB >> 2791565

Effect of cocarboxylase in dogs subjected to experimental septic shock.

G A Lindenbaum1, A J Larrieu, S F Carroll, R A Kapusnick.   

Abstract

We examined the effects of cocarboxylase treatment on both the hemodynamic variables and metabolic function during endotoxic shock in dogs. Cocarboxylase inhibited deterioration in metabolic function as reflected by improved pH and base excess as well as maintenance of normal oxygen consumption. Significant improvements in mean arterial pressure and cardiac index were also seen. Cocarboxylase is a major coenzyme of mitochondrial pyruvate dehydrogenase and may exert its beneficial effects via this complex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791565     DOI: 10.1097/00003246-198910000-00014

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Intravenous thiamine is associated with increased oxygen consumption in critically ill patients with preserved cardiac index.

Authors:  Katherine M Berg; Shiva Gautam; Justin D Salciccioli; Tyler Giberson; Brian Saindon; Michael W Donnino
Journal:  Ann Am Thorac Soc       Date:  2014-12

Review 2.  Thiamine (vitamin B1) in septic shock: a targeted therapy.

Authors:  Ari Moskowitz; Michael W Donnino
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

3.  Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis.

Authors:  Tomoko Fujii; Alessandro Belletti; Anitra Carr; Toshi A Furukawa; Nora Luethi; Alessandro Putzu; Chiara Sartini; Georgia Salanti; Yasushi Tsujimoto; Andrew A Udy; Paul J Young; Rinaldo Bellomo
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

4.  Effectiveness of thiamine therapy in mortality rate in patients with septic shock: A systematic review and meta-analysis.

Authors:  Sukrit Kanchanasurakit; Pornsinee Suthumpoung; Wichai Santimaleeworagun; Chotirat Nakaranurack; Nina S Huynh; Chansinee Srisawat; Monnaree Nunta; Virakarn Chirakan; Surasak Saokaew
Journal:  Int J Crit Illn Inj Sci       Date:  2021-06-29

5.  Combination therapy of thiamine, vitamin C and hydrocortisone in treating patients with sepsis and septic shock: a meta-analysis and trial sequential analysis.

Authors:  Renqi Yao; Yibing Zhu; Yue Yu; Zhixuan Li; Lixue Wang; Liyu Zheng; Jingyan Li; Huibin Huang; Guosheng Wu; Feng Zhu; Zhaofan Xia; Chao Ren; Yongming Yao
Journal:  Burns Trauma       Date:  2021-12-06

6.  The Effect of a Single Dose of Thiamine on Oxygen Consumption in Patients Requiring Mechanical Ventilation for Acute Illness: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Katherine M Berg; Anne V Grossestreuer; Lars W Andersen; Xiaowen Liu; Michael W Donnino
Journal:  Crit Care Explor       Date:  2021-11-17

7.  The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis.

Authors:  José Antenor Araújo de Andrade; Márcia Cristina Paes; Vera Lúcia Freire Cunha Bastos; Jayme da Cunha Bastos Neto; Rachel Novaes Gomes; Márcia Barbosa Águila; Carlos Alberto Mandarim-de-Lacerda; Patrícia Torres Bozza; Sérgio da Cunha; Carlos Roberto Machado Gayer; Natália Pereira de Almeida Nogueira; Sílvio Caetano Alves; Raphael Molinaro Coelho; Mariana Gysele Amarante Teixeira da Cunha
Journal:  J Inflamm (Lond)       Date:  2014-04-24       Impact factor: 4.981

Review 8.  Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation.

Authors:  Ari Moskowitz; Lars W Andersen; David T Huang; Katherine M Berg; Anne V Grossestreuer; Paul E Marik; Robert L Sherwin; Peter C Hou; Lance B Becker; Michael N Cocchi; Pratik Doshi; Jonathan Gong; Ayan Sen; Michael W Donnino
Journal:  Crit Care       Date:  2018-10-29       Impact factor: 9.097

Review 9.  Vitamin therapy in sepsis.

Authors:  Eric L Wald; Colleen M Badke; Lauren K Hintz; Michael Spewak; L Nelson Sanchez-Pinto
Journal:  Pediatr Res       Date:  2021-07-31       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.